S-1 and Photodynamic Therapy in Cholangiocarcinoma
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
In patients with unresectable perihilar cholangiocarcinoma, photodynamic therapy with biliary
stent has been known for palliation of jaundice and improving survival. But most of
therapeutic effects were expected to delay bile duct obstruction rather than to decrease the
tumor. Recently orally available chemotherapeutic agent, S-1 was reported as effective in
patients with bile duct adenocarcinoma. The investigators' aims of study evaluate the
combined effect of photodynamic therapy and S-1.